A phase 1, safety lead-in and randomized, open-label, perioperative study of vorasidenib combined with pembrolizumab in recurrent or progressive enhancing IDH-1 mutant astrocytomas: Trial in progress Meeting Abstract
| Authors: | Wen, P.; Mellinghoff, I.; Clarke, J.; Puduvalli, V.; de Groot, J.; Liu, H.; Tron, A.; Chisamore, M.; Steelman, L.; Hassan, I.; Cloughesy, T. |
| Abstract Title: | A phase 1, safety lead-in and randomized, open-label, perioperative study of vorasidenib combined with pembrolizumab in recurrent or progressive enhancing IDH-1 mutant astrocytomas: Trial in progress |
| Meeting Title: | 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 24 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Nov 16-20 |
| Meeting Location: | Tampa Bay, FL |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-11-01 |
| Start Page: | vii249 |
| Language: | English |
| ACCESSION: | WOS:000888571001276 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noac209.962 |
| Notes: | Meeting Abstract: RTID-02 -- Source: Wos |
